Meeting
2015 ASCO Annual Meeting
Phase I study of bi-weekly nab-paclitaxel and carboplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer.
Authors
Yukihiro Hasegawa
Aomori Prefectural Central Hospital, Aomori, Japan
Yukihiro Hasegawa , Dai Miura , Tomohiro Ota , Junichi Yokouchi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Clinical Trial Registration Number
UMIN000010480
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7529)
DOI
10.1200/jco.2015.33.15_suppl.7529
Abstract #
7529
Poster Bd #
276
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Endostar in combination with radiotherapy and paclitaxel/carboplatin in patients with unresectable non-small cell lung cancer of stage III: Preliminary results of a phase II study.
First Author: S. Ma
Poster
2018 Gastrointestinal Cancers Symposium
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
First Author: Suguru Yamada
Poster
2017 ASCO Annual Meeting
Randomized trial of thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer (NSCLC): Long-term follow-up of Japan Clinical Oncology Group (JCOG) Study JCOG0301.
First Author: Shinji Atagi
Poster
2017 ASCO Annual Meeting
Nivolumab (nivo) + nab-paclitaxel (nab-P) + carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study.
First Author: David Michael Waterhouse